(Q40443884)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27913861%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

title

CXCL12 expression and PD-L1 expression serve as prognostic biomarkers in HCC and are induced by hypoxia (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27913861%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

main subject

biomarker

0 references

hepatocellular carcinoma

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27913861%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

author name string

Dimo Dietrich

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27913861%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

Dominik Bergheim

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27913861%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

Jörn Dietrich

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27913861%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

Jörg C Kalff

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27913861%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

Vittorio Branchi

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27913861%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

Hanno Matthaei

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27913861%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

Glen Kristiansen

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27913861%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

Hans-Peter Fischer

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27913861%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

Diane Goltz

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27913861%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

publication date

2 December 2016

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27913861%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27913861%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

volume

470

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27913861%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27913861%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

page(s)

185-196

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27913861%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00428-016-2051-5

28 March 2020

exact match

0 references

cites work

Management of hepatocellular carcinoma: An update

1 reference

https://api.crossref.org/works/10.1007%2FS00428-016-2051-5

Regulation of PD-L1: a novel role of pro-survival signalling in cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-016-2051-5

Dynamic expression patterns of differential proteins during early invasion of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-016-2051-5

CXCR4 inhibition in tumor microenvironment facilitates anti-programmed death receptor-1 immunotherapy in sorafenib-treated hepatocellular carcinoma in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-016-2051-5

Role of chemokine pathways in hepatobiliary cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-016-2051-5

The PD-1 pathway in tolerance and autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-016-2051-5

Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-016-2051-5

The clinical relevance of the miR-197/CKS1B/STAT3-mediated PD-L1 network in chemoresistant non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-016-2051-5

Overexpression of PD-L1 significantly associates with tumor aggressiveness and postoperative recurrence in human hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-016-2051-5

The Immune Checkpoint Regulator PD-L1 Is Highly Expressed in Aggressive Primary Prostate Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-016-2051-5

Prognostic relevance of proliferation markers (Ki-67, PHH3) within the cross-relation of ERG translocation and androgen receptor expression in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-016-2051-5

Immune checkpoint blockade in hepatocellular carcinoma: current progress and future directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-016-2051-5

GLUT1 and CAIX as intrinsic markers of hypoxia in bladder cancer: relationship with vascularity and proliferation as predictors of outcome of ARCON.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-016-2051-5

A meta-analysis for C-X-C chemokine receptor type 4 as a prognostic marker and potential drug target in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-016-2051-5

Overexpression of PD-L1 and PD-L2 Is Associated with Poor Prognosis in Patients with Hepatocellular Carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-016-2051-5

Activated monocytes in peritumoral stroma of hepatocellular carcinoma foster immune privilege and disease progression through PD-L1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-016-2051-5

EZH2-mediated loss of miR-622 determines CXCR4 activation in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-016-2051-5

Roles of chemokine receptor 4 (CXCR4) and chemokine ligand 12 (CXCL12) in metastasis of hepatocellular carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-016-2051-5

Adipokines in liver diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-016-2051-5

Roles for chemokines in liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-016-2051-5

Involvement of chemokine receptors in breast cancer metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-016-2051-5

Nuclear pattern of CXCR4 expression is associated with a better overall survival in patients with gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-016-2051-5

PD-L1 is a novel direct target of HIF-1α, and its blockade under hypoxia enhanced MDSC-mediated T cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-016-2051-5

Identification of New Players in Hepatocarcinogenesis: Limits and Opportunities of Using Tissue Microarray (TMA).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-016-2051-5

Hepatic inflammation and fibrosis: functional links and key pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-016-2051-5

PD-1 and PD-L1 upregulation promotes CD8(+) T-cell apoptosis and postoperative recurrence in hepatocellular carcinoma patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-016-2051-5

21 January 2018

Cancer statistics, 2014

1 reference

https://api.crossref.org/works/10.1007%2FS00428-016-2051-5

CXCR4 and CXCL12 Expression in Rectal Tumors of Stage IV Patients Before and After Local Radiotherapy and Systemic Neoadjuvant Treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-016-2051-5

Tumor stroma and regulation of cancer development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-016-2051-5

Safety, activity, and immune correlates of anti-PD-1 antibody in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-016-2051-5

Mechanism-driven biomarkers to guide immune checkpoint blockade in cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-016-2051-5

Epigenetic silencing of CXCL12 increases the metastatic potential of mammary carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-016-2051-5

Silencing of epithelial CXCL12 expression by DNA hypermethylation promotes colonic carcinoma metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-016-2051-5

Nivolumab plus ipilimumab in advanced melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-016-2051-5

Lysyl oxidase-like 2 is critical to tumor microenvironment and metastatic niche formation in hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-016-2051-5

Upregulation of circulating PD-L1/PD-1 is associated with poor post-cryoablation prognosis in patients with HBV-related hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-016-2051-5

Induced expression of PD-1, a novel member of the immunoglobulin gene superfamily, upon programmed cell death

21 January 2018

1 reference

12 December 2020

Carbonic anhydrase (CA IX) expression, a potential new intrinsic marker of hypoxia: correlations with tumor oxygen measurements and prognosis in locally advanced carcinoma of the cervix

1 reference

12 December 2020

The expression of PD-L1 APE1 and P53 in hepatocellular carcinoma and its relationship to clinical pathology.

1 reference

12 December 2020

Insights on the CXCL12-CXCR4 axis in hepatocellular carcinoma carcinogenesis

1 reference

12 December 2020